| __timestamp | Axsome Therapeutics, Inc. | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 4279200 | 12402000000 |
| Thursday, January 1, 2015 | 6776987 | 17449000000 |
| Friday, January 1, 2016 | 21199860 | 17834000000 |
| Sunday, January 1, 2017 | 19957616 | 19551000000 |
| Monday, January 1, 2018 | 23495055 | 18265000000 |
| Tuesday, January 1, 2019 | 53647067 | 15607000000 |
| Wednesday, January 1, 2020 | 70244579 | 15410000000 |
| Friday, January 1, 2021 | 58060725 | 16541000000 |
| Saturday, January 1, 2022 | 57947447 | 17482000000 |
| Sunday, January 1, 2023 | 97944000 | 19381000000 |
| Monday, January 1, 2024 | 187077000 | 22873000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical landscape, research and development (R&D) budgets are pivotal. Dr. Reddy's Laboratories Limited, a stalwart in the industry, has consistently invested heavily in R&D, with expenditures peaking at approximately $19.4 billion in 2023. This represents a steady growth of around 56% since 2014. In contrast, Axsome Therapeutics, Inc., a relatively newer player, has shown a remarkable increase in its R&D spending, skyrocketing from $4.3 million in 2014 to nearly $98 million in 2023, marking an astounding growth of over 2,200%.
While Dr. Reddy's maintains a robust and stable R&D budget, Axsome's aggressive investment strategy highlights its commitment to innovation and growth. The data for 2024 is incomplete, but the trends suggest continued strategic investments by both companies. This analysis underscores the dynamic nature of pharmaceutical R&D and the diverse strategies employed by industry leaders.
Comparing Innovation Spending: Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Axsome Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and Dr. Reddy's Laboratories Limited
Research and Development Expenses Breakdown: Teva Pharmaceutical Industries Limited vs Dr. Reddy's Laboratories Limited
R&D Spending Showdown: Genmab A/S vs Axsome Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Dr. Reddy's Laboratories Limited and Blueprint Medicines Corporation
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and TG Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and Soleno Therapeutics, Inc.
Dr. Reddy's Laboratories Limited vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Axsome Therapeutics, Inc. and TG Therapeutics, Inc.
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.
R&D Spending Showdown: Axsome Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.